Invesaro

Stocks Comparison

agilon health vs Progyny: revenue, profit, margins and growth compared

agilon health brought in $5.9B of revenue in fiscal 2025, Progyny $1.3B in fiscal 2025. Revenue changed by -2.1% at agilon health and +10.4% at Progyny on the year before, so Progyny grew faster. agilon health kept -6.6% of its revenue as net profit, Progyny 4.5%. Free cash flow was -$119M at agilon health and $191.8M at Progyny.

Side by side, latest fiscal year

AGLPGNY
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$5.9B$1.3B
Revenue growth-2.1%+10.4%
Net income-$391.3M$58.5M
Net margin-6.6%4.5%
Free cash flow-$119M$191.8M
Free cash flow margin-2.0%14.9%
Earnings per share (diluted)n/a$0.65
Cash$173.7M$112.2M
Debt$35Mn/a
Price to earningsn/a39.1
Market value$1.4B$2B
Dividend yieldn/an/a
Rank by revenue in sector#57 of 523 · Health care#133 of 523 · Health care

Over the years

Revenue
AGL FY2019: $794.4MAGL FY2021: $1.2BAGL FY2021: $1.5BAGL FY2022: $2.4BAGL FY2023: $4.3BAGL FY2024: $6.1BAGL FY2025: $5.9BPGNY FY2019: $105.4MPGNY FY2019: $229.7MPGNY FY2020: $344.9MPGNY FY2021: $500.6MPGNY FY2022: $786.9MPGNY FY2023: $1.1BPGNY FY2024: $1.2BPGNY FY2025: $1.3BFY19FY20FY21FY22FY23FY24FY25
AGL $5.9BPGNY $1.3B
Net income
AGL FY2019: -$282.6MAGL FY2021: -$60.1MAGL FY2021: -$406.5MAGL FY2022: -$106.6MAGL FY2023: -$262.6MAGL FY2024: -$260.2MAGL FY2025: -$391.3MPGNY FY2019: $661KPGNY FY2019: -$8.6MPGNY FY2020: $46.5MPGNY FY2021: $65.8MPGNY FY2022: $30.4MPGNY FY2023: $62MPGNY FY2024: $54.3MPGNY FY2025: $58.5MFY19FY20FY21FY22FY23FY24FY25
AGL -$391.3MPGNY $58.5M
Net margin
AGL FY2019: -35.6%AGL FY2021: -4.9%AGL FY2021: -26.7%AGL FY2022: -4.5%AGL FY2023: -6.1%AGL FY2024: -4.3%AGL FY2025: -6.6%PGNY FY2019: 0.6%PGNY FY2019: -3.7%PGNY FY2020: 13.5%PGNY FY2021: 13.1%PGNY FY2022: 3.9%PGNY FY2023: 5.7%PGNY FY2024: 4.7%PGNY FY2025: 4.5%FY19FY20FY21FY22FY23FY24FY25
AGL -6.6%PGNY 4.5%
Revenue growth
AGL FY2021: +53.4%AGL FY2021: +24.9%AGL FY2022: +57.0%AGL FY2023: +80.7%AGL FY2024: +40.4%AGL FY2025: -2.1%PGNY FY2019: +117.9%PGNY FY2020: +50.1%PGNY FY2021: +45.2%PGNY FY2022: +57.2%PGNY FY2023: +38.3%PGNY FY2024: +7.2%PGNY FY2025: +10.4%FY19FY20FY21FY22FY23FY24FY25
AGL -2.1%PGNY +10.4%
Free cash flow
AGL FY2019: -$106.8MAGL FY2021: -$55MAGL FY2021: -$154.7MAGL FY2022: -$146.2MAGL FY2023: -$172MAGL FY2024: -$71MAGL FY2025: -$119MPGNY FY2019: $1.7MPGNY FY2019: -$4.5MPGNY FY2020: $35.2MPGNY FY2021: $23.9MPGNY FY2022: $77.2MPGNY FY2023: $185.2MPGNY FY2024: $173.7MPGNY FY2025: $191.8MFY19FY20FY21FY22FY23FY24FY25
AGL -$119MPGNY $191.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about agilon health and Progyny

Which is bigger by revenue, agilon health or Progyny?

agilon health is bigger by revenue: $5.9B in fiscal 2025, against $1.3B for Progyny in fiscal 2025.

Which keeps more of its revenue as profit, agilon health or Progyny?

agilon health had a net margin of -6.6% in fiscal 2025; Progyny had 4.5% in fiscal 2025.

Which grew revenue faster, agilon health or Progyny?

In their latest fiscal years revenue changed by -2.1% at agilon health and +10.4% at Progyny.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies